A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234

Clinical trial NCT07546760 · RECRUITING

Trial details

NCT number: NCT07546760
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2026-03-20
Primary completion: 2027-02-04
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.